Influenza Market Research Reports & Industry Analysis
Influenza Industry Research & Market Reports
-
Lateral Flow Assays Market Size By Product (Kits, Readers), By Application (Infectious Disease Testing {Influenza, STDs, Hepatitis, Tuberculosis}, Cardiac Metabolic Testing {CK-MB Testing, Myoglobin, D-dimer, Troponin I}, Pregnancy & Fertility Testing {Pregnancy Testing, Fertility Testing}, Cholesterol Testing, Drug of Abuse), By Technique (Sandwich Assays, Competitive Assays, Multiplex Detection Assays), By End-use (Hospital & Clinics, Diagnostic Laboratories, Homecare Settings), COVID-19 Impact Analysis, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2023 - 2032
... Cholesterol Testing, Drug of Abuse), By Technique (Sandwich Assays, Competitive Assays, Multiplex Detection Assays), By End-use (Hospital & Clinics, Diagnostic Laboratories, Homecare Settings), COVID-19 Impact Analysis, Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market ... Read More
-
Influenza Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures and Forecast, 2015-2033
... (COVID-19 Market Impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on Influenza Tests market for the year 2020 and beyond. ... Read More
-
Gene Vector Market (Vector Type: Lentivirus, Adenovirus, Adeno-associated Virus (AAV), Plasmid DNA, and Others, Disease: Genetic Disorder, Cancer, Infectious Disease, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-
... Market – Scope of Report TMR’s report on the global gene vector market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market ... Read More
-
Europe Influenza Vaccines Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Vaccine Type (Quadrivalent Vaccines and Trivalent Vaccines), Virus Type (Influenza Virus Type A and Influenza Virus Type B), Technology (Egg-based and Cell-based), Route of Administration (Injection and Nasal Spray), and Target Group (Infants, Children, Adults, and Elderly People)
... and Cell-based), Route of Administration (Injection and Nasal Spray), and Target Group (Infants, Children, Adults, and Elderly People) The influenza vaccines market in Europe is expected to grow from US$ 2,261.85 million in 2022 to ... Read More
-
South & Central America Influenza Vaccines Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Vaccine Type (Quadrivalent Vaccines and Trivalent Vaccines), Virus Type (Influenza Virus Type A and Influenza Virus Type B), Technology (Egg-based and Cell-based), Route of Administration (Injection and Nasal Spray), and Target Group (Infants, Children, Adults, and Elderly People)
... B), Technology (Egg-based and Cell-based), Route of Administration (Injection and Nasal Spray), and Target Group (Infants, Children, Adults, and Elderly People) The South & Central America influenza vaccines market is expected to grow from US$ ... Read More
-
Asia Pacific Influenza Vaccines Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Vaccine Type (Quadrivalent Vaccines and Trivalent Vaccines), Virus Type (Influenza Virus Type A and Influenza Virus Type B), Technology (Egg-based and Cell-based), Route of Administration (Injection and Nasal Spray), and Target Group (Infants, Children, Adults, and Elderly People)
... (Egg-based and Cell-based), Route of Administration (Injection and Nasal Spray), and Target Group (Infants, Children, Adults, and Elderly People) The Asia Pacific influenza vaccines market is expected to grow from US$ 1,688.07 million in 2022 ... Read More
-
North America Influenza Vaccines Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Vaccine Type (Quadrivalent Vaccines and Trivalent Vaccines), Virus Type (Influenza Virus Type A and Influenza Virus Type B), Technology (Egg-based and Cell-based), and Route of Administration (Injection and Nasal Spray)
... and Cell-based), and Route of Administration (Injection and Nasal Spray) The North America influenza vaccines market is expected to grow from US$ 3,155.29 million in 2022 to US$ 4,909.00 million by 2028; it is estimated ... Read More
-
Middle East & Africa Influenza Vaccines Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Vaccine Type (Quadrivalent Vaccines and Trivalent Vaccines), Virus Type (Influenza Virus Type A and Influenza Virus Type B), Technology (Egg-based and Cell-based), Route of Administration (Injection and Nasal Spray), and Target Group (Infants, Children, Adults, and Elderly People)
... B), Technology (Egg-based and Cell-based), Route of Administration (Injection and Nasal Spray), and Target Group (Infants, Children, Adults, and Elderly People) The Middle East & Africa influenza vaccines market is expected to grow from US$ ... Read More
-
Influenza Vaccine Market Size, Share & Trends Analysis Report By Vaccine Type, By Indication, By Route Of Administration, By Age Group, By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030
... Growth & Trends The global influenza vaccine market size is expected to reach USD 12.37 billion by 2030 and is set to expand at 6.83% CAGR from 2023 to 2030, according to a new report ... Read More
-
Influenza A Virus, H7N9 Subtype Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Influenza A Virus, H7N9 Subtype Infections - Drugs In Development, 2022, provides an overview of the Influenza ... Read More
-
Seasonal Influenza Therapeutics (SIT) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... than 26.9 million diagnosed incidence cases of SIT are expected across 16 pharmaceutical markets. Roche’s Xofluza (baloxavir) was the most recent entry to the influenza market. The influenza pipeline consists of 108 pharmaceutical therapies spanning ... Read More
-
Preventive Vaccines Market, By Vaccine Type (Live/Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, and Other Vaccine Types), By Disease Type (Pneumococcal, Poliovirus, Hepatitis, Influenza, Measles, Mumps, and Rubella (MMR), and Other Disease Types), and By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
... By Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America)- Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 Preventive vaccines protect people from serious and life-threatening infectious diseases. These vaccines help ... Read More
-
Influenza Vaccine Market Forecasts to 2028 – Global Analysis By Vaccine Type (Trivalent and Quadrivalent), Type (Pandemic, Seasonal and Other Types), Technology (Egg-Based and Cell-Based), Age Group, Route of Administration, Distribution Channel and By Geography
... According to Stratistics MRC, the Global Influenza Vaccine Market is accounted for $8.11 billion in 2022 and is expected to reach $19.34 billion by 2028 growing at a CAGR of 15.58% during the forecast period. ... Read More
-
U.S. Influenza Vaccines Market, by Vaccine Type (Trivalent Vaccines, Quadrivalent Vaccines), by Virus Type (Influenza Virus Type A, Influenza Virus Type B), by Age Group (Pediatrics, Adults) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
... - 2030 Influenza is commonly referred as flu, a contagious respiratory illness which is caused by influenza virus. The virus can cause mild to severe illness, resulting in serious outcomes such as hospitalization or death. ... Read More
-
Global Remote Patient Monitoring Market Size, Segments, Outlook, and Revenue Forecast 2022-2028 By Component Type (Devices, and Software & Services), Product (Vital Sign Monitors, and Special Monitors), Application (Cancer, Cardiovascular Diseases(CVD), Diabetes, Sleep Disorder, Weight management & Fitness Monitoring, Bronchitis, Infections, Virus, Dehydration, and Hypertension), End-User (Hospitals & Clinics, Home Care Settings & Long Term Care Centre’s, Ambulatory Care Centre’s, Passive Exoskeletons, Payers, and Patients) and Region (North America, Europe, Asia Pacific, Latin America Middle East, and Africa (LAMEA))
... management & Fitness Monitoring, Bronchitis, Infections, Virus, Dehydration, and Hypertension), End-User (Hospitals & Clinics, Home Care Settings & Long Term Care Centre’s, Ambulatory Care Centre’s, Passive Exoskeletons, Payers, and Patients) and Region (North America, Europe, ... Read More
-
Global Pediatric Vaccines Market By Type (Monovalent, Multivalent), By Technology (Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Subunit, Recombinant, Polysaccharide, and Conjugate Vaccines), By Indication (Varicella, Diphtheria, Pertussis and Tetanus, Influenza, Human Papilloma Virus, Measles, Mumps and Rubella, Meningococcal Disease, Pneumococcal Disease, Polio, Rotavirus, Other Indications): Global Opportunity Analysis and Industry Forecast, 2021-2031
... Mumps and Rubella, Meningococcal Disease, Pneumococcal Disease, Polio, Rotavirus, Other Indications): Global Opportunity Analysis and Industry Forecast, 2021-2031 The global pediatric vaccine market accounted for $2,1371.73 million in 2021, and is expected to reach $ ... Read More
-
Influenza Vaccine Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... on the growth of the market during the pandemic period. As COVID-19 affects a patient’s respiratory system, they must take vaccines for safety purposes. Thus, the demand for influenza vaccines has increased. The article titled ... Read More
-
Vaccine Adjuvants Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... exports due to facility closures during the COVID-19 pandemic had a short-term adverse impact on the market's growth in the pandemic's preliminary phase due to supply chain disruptions and the unavailability of human resources. However, ... Read More
-
Respiratory Syncytial Virus (RSV) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Infections - Drugs In Development, 2022, provides an overview of the Respiratory Syncytial Virus (RSV) Infections (Infectious Disease) pipeline landscape. Respiratory syncytial virus (RSV) infection is a respiratory disease. It infects the lungs and breathing ... Read More
-
Influenza Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Vaccine Type (Quadrivalent Vaccines and Trivalent Vaccines), Virus Type (Influenza Virus Type A and Influenza Virus Type B), Technology (Egg-based and Cell-based), Route of Administration (Injection and Nasal Spray), and Target Group (Infants, Children, Adults, and Elderly)
... Route of Administration (Injection and Nasal Spray), and Target Group (Infants, Children, Adults, and Elderly) The influenza vaccines market is expected to grow from US$ 7,478.53 million in 2021 to US$ 12,272.49 million by 2028. ... Read More
-
Global Flu Vaccine Market - 2022-2029
... during the forecast period (2022-2029). The flu vaccine is inactivated, indicating that it includes the killed influenza virus, or a recombinant vaccine, implying that it was made without exploiting virus particles. Flue vaccination is safe ... Read More
-
Middle East & Africa Influenza Vaccines Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Vaccine Type (Quadrivalent Vaccines and Trivalent Vaccines), Virus Type (Influenza Virus Type A and Influenza Virus Type B), Technology (Egg-based and Cell-based), and Route of Administration (Injection and Nasal Spray)
... B), Technology (Egg-based and Cell-based), and Route of Administration (Injection and Nasal Spray) The influenza vaccines market in Middle East & Africa is expected to grow from US$ 374.35 million in 2022 to US$ 533.85 ... Read More
-
Europe Influenza Vaccines Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Vaccine Type (Quadrivalent Vaccines and Trivalent Vaccines), Virus Type (Influenza Virus Type A and Influenza Virus Type B), Technology (Egg-based and Cell-based), and Route of Administration (Injection and Nasal Spray)
... and Cell-based), and Route of Administration (Injection and Nasal Spray) The influenza vaccines market in Europe is expected to grow from US$ 2,261.85 million in 2022 to US$ 3,424.02 million by 2028. It is estimated ... Read More
-
South & Central America Influenza Vaccines Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Vaccine Type (Quadrivalent Vaccines and Trivalent Vaccines), Virus Type (Influenza Virus Type A and Influenza Virus Type B), Technology (Egg-based and Cell-based), and Route of Administration (Injection and Nasal Spray)
... B), Technology (Egg-based and Cell-based), and Route of Administration (Injection and Nasal Spray) The influenza vaccines market in South & Central America is expected to grow from US$ 497.54 million in 2022 to US$ 736.35 ... Read More
-
Oncolytic Virus - Competitive Landscape, 2022
... type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered • Global coverage Oncolytic Virus: Understanding Oncolytic Virus: Overview Oncolytic viruses (OVs) are organisms able ... Read More
Research Assistance
